The British government’s reported plans to extend its contract with U.S. technology company Palantir for work with England’s National Health Service (NHS) have prompted criticism from the Palestine Solidarity Campaign (PSC), which is calling for the company to be removed from the publicly funded healthcare system.
Reports published by the Financial Times, The Telegraph and The Times indicate that the UK government is considering extending Palantir’s involvement in NHS England, raising renewed questions about the company’s defense-related activities, public accountability and the use of its technology in healthcare.
Palestine Solidarity Campaign Condemns Proposed Contract Extension
In a statement issued November 6, 2026, the Palestine Solidarity Campaign criticized the reported plans, arguing that additional government funding for Palantir would conflict with Britain’s stated position on companies linked to Israel’s military operations.
Lewis Backon, PSC campaigns officer, said:
“It is shameful that the government plans to extend Palantir’s contract with NHS England, handing this disgraced company millions more pounds of public money.”
The organization alleges that Palantir’s technology contracts with the Israeli military make the company complicit in alleged violations of international law involving Palestinians.
PSC also questioned the consistency of the government’s approach, citing the British foreign secretary’s commitment to take action against businesses facilitating Israel’s occupation of Palestinian territories.
Campaign Group Calls for Immediate Government Action
Backon argued that delaying decisions about Palantir’s future contracts would not address the organization’s concerns about the company’s current activities.
The campaign group maintains that companies it considers involved in alleged human rights violations should face immediate consequences rather than potential restrictions on future government contracts.
PSC linked its opposition to Palantir’s NHS involvement to the continuing conflict in Gaza and Israeli military operations in the West Bank.
These allegations reflect the campaign group’s position and should not be interpreted as independent findings establishing Palantir’s legal responsibility for alleged violations.
Palantir’s Role in the NHS Faces Growing Scrutiny
Palantir, a U.S.-based data analytics and software company, has been involved in the NHS Federated Data Platform, an initiative designed to help healthcare organizations integrate and analyze operational information.
The platform is intended to support hospital management, resource allocation and healthcare planning across England’s publicly funded health system.
However, Palantir’s participation has generated opposition from healthcare workers, patient advocacy organizations and members of the British Parliament.
Critics have raised concerns about public trust, the company’s defense contracts and whether its technology is necessary for the NHS.
Parliamentary Committees Raise Concerns Over Public Trust
According to the Palestine Solidarity Campaign, two parliamentary select committees have urged the government to end its contractual relationship with Palantir.
The House of Commons Health and Social Care Committee identified “serious mistrust” of Palantir among members of the public.
The committee also concluded that there are “other tools that can deliver the same or similar benefits.”
Those findings have strengthened arguments from opponents who believe the NHS should consider alternative technology providers.
For U.S. readers, the controversy highlights broader questions surrounding the role of private technology contractors in publicly funded healthcare, particularly when those companies also maintain relationships with military and intelligence organizations.
Some NHS Hospitals Question Palantir Technology’s Benefits
Opposition to Palantir’s NHS involvement has also emerged among individual healthcare organizations.
According to PSC, multiple NHS trusts have declined to adopt the company’s technology, raising questions about whether the platform offers sufficient improvements over existing systems.
The University Hospitals of North Midlands NHS Trust reportedly assessed the technology and stated that “it does not appear to provide functionality over and above what we have already.”
The assessment reflects concerns about the practical value of introducing additional technology into established hospital operations.
Debate Extends Beyond Healthcare Technology
The dispute over Palantir’s NHS contract extends beyond the technical capabilities of its software.
For campaign organizations, the central issue is whether public institutions should award contracts to companies whose activities in other sectors have generated significant human rights concerns.
For policymakers, the controversy also involves balancing healthcare modernization, operational efficiency, procurement accountability and public confidence.
The reported extension has renewed debate over how the British government evaluates technology contractors and whether their activities outside the healthcare sector should influence public procurement decisions.
Government Faces Pressure Over Palantir’s Future in NHS England
The Palestine Solidarity Campaign is urging the British government to reverse its reported plans and remove Palantir from the NHS.
The organization argues that maintaining the company’s healthcare contracts would undermine government commitments concerning businesses associated with Israel’s military activities.
The controversy places renewed attention on the future of the NHS Federated Data Platform and the government’s approach to selecting private technology providers.
As discussions surrounding the reported contract extension continue, the dispute underscores the growing tension between government technology procurement, healthcare modernization and demands for greater corporate accountability.
Discover more from Wire Service Canada
Subscribe to get the latest posts sent to your email.